Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Cancer Res. 2011 Aug 1;71(15):5144-53. doi: 10.1158/0008-5472.CAN-11-0425. Epub 2011 Jun 13.
MicroRNA profiling in isogenic models of cellular transformation involving either breast epithelial cells or fibroblasts reveals that expression of miR-193a is lower in transformed cells than in nontransformed cells. The transcription factors Max and RXRα bind directly to the miR-193a promoter and inhibit miR-193a expression during transformation. miR-193a inhibits cellular transformation by directly targeting the 3' untranslated regions of PLAU and K-Ras. Interestingly, miR-193a controls anchorage-independent growth in soft agar through K-Ras, whereas it affects invasive growth through PLAU. miR-193a overexpression inhibits the tumorigenicity of developmentally diverse but not all cancer cell types, and it inhibits tumor growth in colon- and breast-derived xenografts. Finally, expression of miR-193a is inversely correlated with PLAU and K-Ras in human colon adenocarcinomas. Thus, a pathway in which Max and RXRα inhibit miR-193a expression, thereby activating the PLAU and K-Ras oncogenes is important for distinct aspects of cellular transformation, as well as tumor growth and colon (and perhaps other types of) cancer.
微 RNA 图谱分析在涉及乳腺上皮细胞或成纤维细胞的细胞转化同基因模型中显示,miR-193a 的表达在转化细胞中低于非转化细胞。转录因子 Max 和 RXRα 直接结合到 miR-193a 启动子上,并在转化过程中抑制 miR-193a 的表达。miR-193a 通过直接靶向 PLAU 和 K-Ras 的 3'非翻译区来抑制细胞转化。有趣的是,miR-193a 通过 K-Ras 控制软琼脂中的锚定非依赖性生长,而通过 PLAU 影响浸润性生长。miR-193a 过表达抑制了不同发育来源但并非所有癌细胞类型的致瘤性,并抑制了结肠和乳腺衍生异种移植物中的肿瘤生长。最后,miR-193a 的表达与人结肠腺癌中的 PLAU 和 K-Ras 呈负相关。因此,Max 和 RXRα 抑制 miR-193a 表达,从而激活 PLAU 和 K-Ras 癌基因的途径,对于细胞转化以及肿瘤生长和结肠(可能还有其他类型的)癌症的不同方面都很重要。